focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,550.00
Bid: 1,530.00
Ask: 1,570.00
Change: 10.00 (0.65%)
Spread: 40.00 (2.614%)
Open: 1,550.00
High: 1,550.00
Low: 1,550.00
Prev. Close: 1,540.00
CER Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

26 Jul 2007 11:13

Celtic Resources Holdings PLC26 July 2007 Celtic Resources Holdings Plc ("Celtic Resources" or "the Company") Purchase of remaining 25% of Zherek Gold Mine Celtic Resources is pleased to announce that it has purchased the remaining 25%of Zherek LLP for US$660,000 cash to take its ownership to 100%. The purchaseof the additional 25% in Zherek increases Celtic's total attributable gold resources by approximately 210,000 ounces gold to 4.23 million ounces gold. The 100% ownership of Zherek enables Celtic to develop Zherek as an integralpart of the Company's plans to consistently produce more than 100,000 oz/yearfrom their two Kazakhstan gold mines. Celtic's Suzdal and Zherek gold mines,separated by only 28km, can take advantage of their close proximity with thetreatment of the refractory components of the Zherek ore in the fullyfunctioning Suzdal BIOX plant. As of 1st January, 2006, Zherek had Measured, Indicated and Inferred sulphideore resources of 5.43 million tonnes at 4.8 g/t gold containing 841,000 ounces*.In 2006, gold production from the open pit and heap leach operation on oxide ores at Zherek was 9,735 oz, compared to 17,406 oz in 2005 as transitional oreswere encountered and recoveries and grades declined. Expected production in 2007is 10,000 ounces. Celtic is currently evaluating methods to treat the transitional ores in 2008and the sulphide ores in 2009 and expects the heap leaching of oxide ores tocontinue into 2008. Kevin Foo, Managing Director, commented, "Now we have 100% ownership of Zherek,we can focus on the next stage of planning to treat the substantial sulphideores in 2009, once the oxide ores are depleted. Test work and feasibility studies continue and we expect to have a decision on Zherek's optimumdevelopment route in early 2008." For further information please contact: Kevin Foo / Jonathan Scott-Barrett Jane Stacey / Leesa PetersCeltic Resources Holdings Plc Conduit PRTel: + 44 (0)20 7921 8800 Tel: +44 (0)20 7429 6606 / (0)792 292 3306Investors@celticresources.com jane@conduitpr.com Simon Raggett / Braden Saunders Peter KrensStrand Partners Limited Mirabaud Securities LimitedTel: +44 (0) 20 7409 3494 Tel: +44 (0)20 7878 3362 www.celticresources.com * Information extracted from an independent report prepared by SRK Consulting(UK) Ltd (SRK) which was prepared under the direction of Dr. Mike Armitage,CEng, CGeol. Dr Mike Armitage is a full time employee, and the ManagingDirector, of SRK and a Member of the Institute of Materials, Metals and Mining(IMMM) which is a Recognised Overseas Professional Organisation (ROPO) includedin a list promulgated by the Australian Stock Exchange from time to time. DrMike Armitage has sufficient experience which is relevant to the style ofmineralisation and type of deposit under consideration and to the activity whichhe is undertaking to qualify as a competent Person as defined in the 2004Edition of the Australasian Code for Reporting of Exploration Results, MineralResources and Ore Reserves. Dr Mike Armitage consents to the inclusion in thereport of the matters based on his information. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award
2nd Mar 20227:00 amRNSExercise of Options, PDMR Shareholding & TVR
21st Feb 20223:08 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSShare purchase for Employee Share Option Scheme
15th Feb 20227:00 amRNSRecognised in Two Gartner Market Guide Reports
4th Feb 202211:37 amRNSResult of AGM
31st Jan 20227:00 amRNSConfirmation of Board Appointment
27th Jan 20222:25 pmRNSHolding(s) in Company
24th Jan 20222:05 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSCompletion of Implementation for Norlys
14th Dec 20217:00 amRNSBoard Retirement and Proposed Appointment
26th Nov 20218:37 amRNSPDMR and PCA Shareholding
22nd Nov 20217:00 amRNSFinal Results
16th Nov 20212:42 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSRelease of Cerillion 21.2
4th Oct 20217:02 amRNSTrading Update
28th Sep 20217:00 amRNSContracts worth £4.2m with OpenNet
23rd Sep 20216:15 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSOpening of Bulgaria office
8th Sep 20217:00 amRNSInvestor Presentation
22nd Jul 20214:24 pmRNSHolding(s) in Company
13th Jul 202111:03 amRNSHolding(s) in Company
6th Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSGrant of Options
18th Jun 20217:00 amRNSEmployee Share Option Scheme
10th Jun 202111:35 amRNSDirector/PDMR shareholding
27th May 20216:03 pmRNSReplacement: Director/PDMR Shareholding
27th May 20213:50 pmRNSDirector/PDMR Shareholding
24th May 20214:59 pmRNSExercise of Options and Total Voting Rights
21st May 202112:26 pmRNSDirector/PDMR Shareholding
17th May 20214:33 pmRNSHolding(s) in Company
17th May 20217:00 amRNSInterim Results
19th Apr 20217:00 amRNSHalf Year Trading Update
29th Mar 20217:00 amRNSLargest Ever Contract Win
17th Mar 20215:47 pmRNSShare Purchase for Long-Term Incentive Plan
12th Mar 20215:43 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSMajor Channel Partner Yields First Contract
11th Feb 20215:14 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSPDMR Share Transfer
5th Feb 20219:31 amRNSResult of AGM
4th Feb 20213:00 pmRNSHolding(s) in Company
4th Feb 202112:09 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:13 pmRNSDirector/PDMR shareholding
30th Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20206:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.